Buscar
Mostrando ítems 21-30 de 2651
Mild versus severe COVID-19: Laboratory markers
The number of COVID-19 patients is dramatically increasing worldwide. Treatment in intensive care units
(ICU) has become a major challenge; therefore, early recognition of severe forms is absolutely essential
for timely ...
The potential application of probiotics and prebiotics for the prevention and treatment of COVID-19
COVID-19 is a pandemic disease caused by the novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
This new viral infection was first identified in China in December 2019, and it has subsequently ...
Is it possible to use proton pump inhibitors in COVID-19 treatment and pro‐ phylaxis?
Coronaviruses (CoV), discovered after 1960, caused human life-threatening outbreaks.
SARS-CoV2, which appeared in Wuhan, China in December 2019, causing Severe Acute
Respiratory Syndrome and has different features than ...
Estrategias de abordaje terapéuticas del paciente con secuelas pulmonares en el síndrome post COVID-19 aplicables en el escenario de atención primaria en usuarios mayores de 18 años
(2022)
El síndrome post COVID-19 es una entidad de reciente aparición, definida como la persistencia de síntomas 12 semanas posterior a la infección por COVID-19. Tiene una alta prevalencia sin embargo su identificación continúa ...
Gastrointestinal symptoms, pathophysiology, and treatment in COVID-19
The novel coronavirus Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has emerged and is responsible for the Coronavirus Disease 20191 global pandemic. Coronaviruses, including SARS-CoV-2, are strongly associated ...
Biomarkers of COVID-19 and technologies to combat SARS-CoV-2
Due to the unprecedented public health crisis caused by COVID-19, our first contribution to the newly
launching journal, Advances in Biomarker Sciences and Technology, has abruptly diverted to focus on
the current pandemic. ...
Expanding accessibility: Outpatient intensive treatment for substance use disorder during covid-19 pandemic
(Elsevier Ireland, 2020-10)
The COVID-19 pandemic has impacted mental health, particularly for people with preexisting conditions such as Substance Use Disorders (SUD) (Brooks et al., 2020; Volkow, 2020; Panamerican Health Organization, 2016). Since ...
The role of psychiatry in treating burnout among nurses during the COVID-19 pandemic
The prevalence of burnout among US registered nurses ranges from 35 to 45%. In one study, nurses had
twice the rate of depression compared with other health care professionals. Owing to the Covid-19
pandemic, burnout is ...
CRISPR/Cas13: A potential therapeutic option of COVID-19
The novel coronavirus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
can be considered as the most important current global issue, as it has caused the novel
coronavirus disease (COVID-19) pandemic, ...